LIP
JAZZ icon

Lighthouse Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lighthouse Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.38M Buy
+33,727
New +$5.89M 0.22% 153
2025
Q1 		– Sell
-24,500
Closed -$3.02M – 560
2024
Q4 		$3.02M Buy
+24,500
New +$2.89M 0.1% 236

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Lighthouse Investment Partners's JAZZ Position: Q1 2026 in Review

Lighthouse Investment Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 33,727 shares worth $6.38M. The stake represents 0.22% of the portfolio and ranks #153 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in JAZZ as recently as Q4 2024.

Lighthouse Investment Partners first reported a position in JAZZ in Q4 2024 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Lighthouse Investment Partners held 33,727 shares of Jazz Pharmaceuticals worth $6.38M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Lighthouse Investment Partners position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.22% of Lighthouse Investment Partners's portfolio in Q1 2026, its #153 holding.
  • Lighthouse Investment Partners first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.